More gene therapy drug developers than ever are realizing the potential of gene therapies to treat a range of ophthalmic diseases. These therapies cannot be pioneered without provision of important services, from high quality preclinical models to specialist equipment that assesses the effectiveness of treatments.
Partnering with us provides a unique platform to establish yourself as the go-to company for anyone developing ophthalmic gene therapies.
- Showcase your expertise to leading organizations by securing a virtual exhibition booth
- Secure a spot on our expert speaker faculty to demonstrate thought leadership and drive brand exposure
- Maximise the balance of 2:1 live content and targeted online networking to generate leads and build new relationships with gene therapy pioneers
- Embrace the tech to meet your 2020 commercial objectives and educate decision makers on how your expertise can deliver gene therapies to patients more effectively